Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study.

Peppone LJ, Mustian KM, Rosier RN, Carroll JK, Purnell JQ, Janelsins MC, Morrow GR, Mohile SG.

Support Care Cancer. 2014 Jan;22(1):245-51. doi: 10.1007/s00520-013-1967-4. Epub 2013 Sep 17.

2.

Lead induces an osteoarthritis-like phenotype in articular chondrocytes through disruption of TGF-β signaling.

Holz JD, Beier E, Sheu TJ, Ubayawardena R, Wang M, Sampson ER, Rosier RN, Zuscik M, Puzas JE.

J Orthop Res. 2012 Nov;30(11):1760-6. doi: 10.1002/jor.22117. Epub 2012 Apr 19.

3.

Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.

Kim KO, Sampson ER, Maynard RD, O'Keefe RJ, Chen D, Drissi H, Rosier RN, Hilton MJ, Zuscik MJ.

J Cell Biochem. 2012 Jun;113(6):2156-66. doi: 10.1002/jcb.24089.

4.

High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury.

Mooney RA, Sampson ER, Lerea J, Rosier RN, Zuscik MJ.

Arthritis Res Ther. 2011;13(6):R198. doi: 10.1186/ar3529. Epub 2011 Dec 7.

5.

Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.

Sampson ER, Hilton MJ, Tian Y, Chen D, Schwarz EM, Mooney RA, Bukata SV, O'Keefe RJ, Awad H, Puzas JE, Rosier RN, Zuscik MJ.

Sci Transl Med. 2011 Sep 21;3(101):101ra93. doi: 10.1126/scitranslmed.3002214.

6.

The effect of various vitamin D supplementation regimens in breast cancer patients.

Peppone LJ, Huston AJ, Reid ME, Rosier RN, Zakharia Y, Trump DL, Mustian KM, Janelsins MC, Purnell JQ, Morrow GR.

Breast Cancer Res Treat. 2011 May;127(1):171-7. doi: 10.1007/s10549-011-1415-4. Epub 2011 Mar 8.

7.

Establishment of an index with increased sensitivity for assessing murine arthritis.

Sampson ER, Beck CA, Ketz J, Canary KL, Hilton MJ, Awad H, Schwarz EM, Chen D, O'Keefe RJ, Rosier RN, Zuscik MJ.

J Orthop Res. 2011 Aug;29(8):1145-51. doi: 10.1002/jor.21368. Epub 2011 Mar 3.

8.

The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model.

Sampson ER, Martin BA, Morris AE, Xie C, Schwarz EM, O'Keefe RJ, Rosier RN.

J Bone Miner Res. 2011 Jun;26(6):1283-94. doi: 10.1002/jbmr.336.

9.

The histone deacetylase inhibitor vorinostat selectively sensitizes fibrosarcoma cells to chemotherapy.

Sampson ER, Amin V, Schwarz EM, O'Keefe RJ, Rosier RN.

J Orthop Res. 2011 Apr;29(4):623-32. doi: 10.1002/jor.21274. Epub 2010 Oct 18.

10.

Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial.

Peppone LJ, Mustian KM, Janelsins MC, Palesh OG, Rosier RN, Piazza KM, Purnell JQ, Darling TV, Morrow GR.

Clin Breast Cancer. 2010 Jun;10(3):224-9. doi: 10.3816/CBC.2010.n.030.

11.

Beta-catenin, cartilage, and osteoarthritis.

Wu Q, Zhu M, Rosier RN, Zuscik MJ, O'Keefe RJ, Chen D.

Ann N Y Acad Sci. 2010 Mar;1192:344-50. doi: 10.1111/j.1749-6632.2009.05212.x. Review.

12.

The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review.

Peppone LJ, Hebl S, Purnell JQ, Reid ME, Rosier RN, Mustian KM, Palesh OG, Huston AJ, Ling MN, Morrow GR.

Osteoporos Int. 2010 Jul;21(7):1133-49. doi: 10.1007/s00198-009-1136-2. Epub 2009 Dec 4. Review.

13.

Smurf2 induces degradation of GSK-3beta and upregulates beta-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage.

Wu Q, Huang JH, Sampson ER, Kim KO, Zuscik MJ, O'Keefe RJ, Chen D, Rosier RN.

Exp Cell Res. 2009 Aug 15;315(14):2386-98. doi: 10.1016/j.yexcr.2009.05.019. Epub 2009 May 27.

14.

Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.

Wu Q, Kim KO, Sampson ER, Chen D, Awad H, O'Brien T, Puzas JE, Drissi H, Schwarz EM, O'Keefe RJ, Zuscik MJ, Rosier RN.

Arthritis Rheum. 2008 Oct;58(10):3132-44. doi: 10.1002/art.23946.

15.

Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice.

Zhu M, Tang D, Wu Q, Hao S, Chen M, Xie C, Rosier RN, O'Keefe RJ, Zuscik M, Chen D.

J Bone Miner Res. 2009 Jan;24(1):12-21. doi: 10.1359/jbmr.080901.

16.

Erythropoietin accelerates functional recovery after peripheral nerve injury.

Elfar JC, Jacobson JA, Puzas JE, Rosier RN, Zuscik MJ.

J Bone Joint Surg Am. 2008 Aug;90(8):1644-53. doi: 10.2106/JBJS.G.00557.

17.

Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction.

Zhu M, Chen M, Zuscik M, Wu Q, Wang YJ, Rosier RN, O'Keefe RJ, Chen D.

Arthritis Rheum. 2008 Jul;58(7):2053-64. doi: 10.1002/art.23614.

18.

Quantification of massive allograft healing with dynamic contrast enhanced-MRI and cone beam-CT: a pilot study.

Ehrhart N, Kraft S, Conover D, Rosier RN, Schwarz EM.

Clin Orthop Relat Res. 2008 Aug;466(8):1897-904. doi: 10.1007/s11999-008-0293-5. Epub 2008 Jun 10.

19.

Teriparatide (1-34 human PTH) regulation of osterix during fracture repair.

Kaback LA, Soung do Y, Naik A, Geneau G, Schwarz EM, Rosier RN, O'Keefe RJ, Drissi H.

J Cell Biochem. 2008 Sep 1;105(1):219-26. doi: 10.1002/jcb.21816.

20.

Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis.

Eliseev RA, Dong YF, Sampson E, Zuscik MJ, Schwarz EM, O'Keefe RJ, Rosier RN, Drissi MH.

Oncogene. 2008 Jun 5;27(25):3605-14. doi: 10.1038/sj.onc.1211020. Epub 2008 Jan 28.

PMID:
18223689

Supplemental Content

Loading ...
Support Center